Covetrus reports 2020 sales up 9%, shrinking loss

Portland-based Covetrus Inc. (Nasdaq: CVET) on Monday reported 2020 net sales of $4.3 billion, including $1.1 billion in the fourth-quarter — year-over-year increases of 9% and 11% respectively.

For the year, the animal-health company reported a loss of $19 million, or 22 cents per share, compared to $980 million, or $9.14 per share, in the previous year. During 2019, the company recorded a goodwill impairment charge of $939 million.

For the fourth quarter, Covetrus had a loss of $4 million, or 4 cents per share, compared to a loss of $37 million, or 33 cents per share, during Q4 2019. Read more

Related Posts

Business Leaders: Deborah Bronk steers Bigelow Lab expansion to boost reach, programming

Deborah Bronk is president, CEO and a senior research scientist at Bigelow Laboratory for Ocean Sciences in East Boothbay, which will...

24 March 2025

UNE retains R2 Research status, reinforcing leadership in scientific advancement

The University of New England has retained its status as one of the country’s leading research universities with the recent release...

23 March 2025

Maine college students investigate health effects of forever chemicals

Two dozen Maine college students are investigating the public health effects of forever chemicals by using zebrafish as human stand-ins and...

21 March 2025